Ad is loading...
AVTX
Price
$9.65
Change
-$1.25 (-11.47%)
Updated
Nov 21 closing price
CELC
Price
$12.78
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
118 days until earnings call
Ad is loading...

AVTX vs CELC

Header iconAVTX vs CELC Comparison
Open Charts AVTX vs CELCBanner chart's image
Avalo Therapeutics
Price$9.65
Change-$1.25 (-11.47%)
Volume$88.48K
CapitalizationN/A
Celcuity
Price$12.78
Change-$0.00 (-0.00%)
Volume$261.76K
CapitalizationN/A
AVTX vs CELC Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AVTX vs. CELC commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and CELC is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (AVTX: $9.65 vs. CELC: $12.73)
Brand notoriety: AVTX and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 228% vs. CELC: 78%
Market capitalization -- AVTX: $100.97M vs. CELC: $472.66M
AVTX [@Biotechnology] is valued at $100.97M. CELC’s [@Biotechnology] market capitalization is $472.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whileCELC’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • CELC’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 6 TA indicator(s) are bullish while CELC’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 6 bullish, 4 bearish.
  • CELC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than CELC.

Price Growth

AVTX (@Biotechnology) experienced а -28.41% price change this week, while CELC (@Biotechnology) price change was -9.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

AVTX is expected to report earnings on Apr 01, 2024.

CELC is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($473M) has a higher market cap than AVTX($101M). AVTX YTD gains are higher at: 6.044 vs. CELC (-12.629). AVTX has higher annual earnings (EBITDA): -35.84M vs. CELC (-85.45M). CELC has more cash in the bank: 264M vs. AVTX (81.9M). AVTX has less debt than CELC: AVTX (550K) vs CELC (97.2M). AVTX has higher revenues than CELC: AVTX (820K) vs CELC (0).
AVTXCELCAVTX / CELC
Capitalization101M473M21%
EBITDA-35.84M-85.45M42%
Gain YTD6.044-12.629-48%
P/E Ratio0.10N/A-
Revenue820K0-
Total Cash81.9M264M31%
Total Debt550K97.2M1%
FUNDAMENTALS RATINGS
AVTX vs CELC: Fundamental Ratings
AVTX
CELC
OUTLOOK RATING
1..100
6361
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5983
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
3250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (40) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AVTX (85) in the Pharmaceuticals Other industry. This means that CELC’s stock grew somewhat faster than AVTX’s over the last 12 months.

CELC's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that CELC’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as CELC (98) in the Miscellaneous Commercial Services industry. This means that AVTX’s stock grew similarly to CELC’s over the last 12 months.

AVTX's Price Growth Rating (59) in the Pharmaceuticals Other industry is in the same range as CELC (83) in the Miscellaneous Commercial Services industry. This means that AVTX’s stock grew similarly to CELC’s over the last 12 months.

AVTX's P/E Growth Rating (88) in the Pharmaceuticals Other industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that AVTX’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXCELC
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHCHY13.69-0.04
-0.32%
Anhui Conch Cement Co., Ltd.
HEINY36.73-0.40
-1.08%
Heineken N.V.
PHRRF0.15N/A
-1.29%
PharmaTher Holdings Ltd.
DLAKY6.37-0.11
-1.70%
Deutsche Lufthansa AG
LTSRF0.15-0.01
-3.50%
Lotus Resources Ltd

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.39%
PLRX - CELC
42%
Loosely correlated
+0.94%
INZY - CELC
41%
Loosely correlated
-3.58%
SNDX - CELC
40%
Loosely correlated
-2.19%
ABOS - CELC
39%
Loosely correlated
-2.53%
AVTX - CELC
39%
Loosely correlated
-11.47%
More